Dendritic Killer Cell-based Immunotherapy for Solid Tumors

NCT02882659 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Neoplasms
Hepatocellular Carcinoma
Neoplasm Metastasis

Interventions

BIOLOGICAL: Dendritic Killer Cell (DKC)

Sponsor

FullHope Biomedical Co., Ltd.

Collaborators

[object Object]